There and back again: An immunotherapy tale.

作者信息

Guo Yizhan, Krupnick Alexander Sasha

机构信息

Division of Thoracic Surgery, Department of Surgery, University of Virginia, Charlottesville, Va.

出版信息

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1771-1774. doi: 10.1016/j.jtcvs.2017.11.102. Epub 2017 Dec 23.

DOI:10.1016/j.jtcvs.2017.11.102

PMID:29409610

Abstract

摘要

相似文献

[1]

There and back again: An immunotherapy tale.

J Thorac Cardiovasc Surg. 2018-4

[2]

KEYNOTE-024: Unlocking a pathway to lung cancer cure?

J Thorac Cardiovasc Surg. 2018-4

[3]

Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels.

Acta Oncol. 2020-3

[4]

[Immuno-checkpoint inhibitor resistance and strategy in lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi. 2020-7-12

[5]

Baseline corticosteroids reduce activity of PD-L1 blockade.

Lancet Oncol. 2018-10

[6]

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy.

JAMA Oncol. 2018-2-1

[7]

Immunotherapeutic approaches for small-cell lung cancer.

Nat Rev Clin Oncol. 2020-2-13

[8]

Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?

Cancer. 2018-7-15

[9]

Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer.

Korean J Intern Med. 2018-9-3

[10]

Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer.

Immunotherapy. 2019-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

There and back again: An immunotherapy tale.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献